Documents par Axes stratégiques

THE GLOBAL FUND - RESULTS REPORT 2018

The impact of investments in health can be measured in many ways, and one of the most important measures is how many lives are saved. Health programs supported by the Global Fund partnership have saved 27 million lives as of the end of 2017.

Credit for this achievement is shared by policymakers and activists, scientists and community health workers, donors, drug makers and many more partners.
Overall, the number of deaths caused by AIDS, TB and malaria each year has been reduced by onethird since 2002 in countries where the Global Fund invests.

English

12 years of implementing PMTCT services in cameroon 2000-2012

From February 2000 to December 2012, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), a global leader and implementing partner for prevention of mother-to-child transmission of HIV (PMTCT) services, supported Cameroon Baptist Convention Health Services (CBCHS), a local nonprofit health-care organization in Cameroon, in initiating and implementing high-quality services for PMTCT. The program aimed at providing and scaling up PMTCT services in view of reaching virtual elimination of HIV infection in infants and children.

English

Plan d’Action Mondial pour les Vaccins 2011-2020

Le Plan d’action mondial pour les vaccins (Global Vaccine Action Plan, soit GVAP) est un cadre approuvé par l’Assemblée mondiale de la Santé en mai 2012, établi pour
concrétiser la vision de la Décennie de la vaccinations en offrant un accès universel à la vaccination. La mission décrite dans le GVAP est simple : améliorer la santé en
étendant tous les avantages de la vaccination à tous les individus, quel que soit l’endroit où ils sont nés, qui ils sont et où ils vivent d’ici à 2020 et au-delà.

French

ANRS RAPPORT D'ACTIVITES 2017-2018

L’ANRS (Agence nationale de recherches sur le sida et les hépatites virales) a été créée en 1988 sur décision gouvernementale, dans un contexte d’urgence scientifique et de santé publique. Elle mobilise les chercheurs du Nord et du Sud,de toutes disciplines, et quelle que soient leurs appartenances, autour de questions scientifiques identifiées comme prioritaires et pour lesquelles la production de résultats est susceptible de contribuer :
– à une meilleure compréhension des mécanismes biologiques (recherche fondamentale)

French

SEXUALLY TRANSMITTED DISEASES IN WOMEN ATTENDING FAMILY PLANNING CLINICS IN YAOUNDE - CAMEROON

STDs are a major public health problem in the developing as well as developed world. Over 250 million new cases of cllrable SrDs occur annually world wide~ meanwhile lout of every 10 sexually active individual is infected by an STD. 400/0 of individuals of the reproductive age in Cameroon are exposed to at least I STD. Chlamydial infection has replaced gonoco,ccal infection with highest prevalence in Cameroon and world wide. An average of 20~/0 of women attending Family Planning, antenatal and other clinics in Africa has trichomonas.

French

APPORT DE L'HYSTEROSONOGRAPHIE DANS LE DIAGNOSTIC DES LESIONS MUQUEUSES ET SOUS MUQUEUSES UTERINES

Les pathologies de la muqueuse et de la sous muqueuse utérine représentent plus de la moitié des motifs de consultation en pratique gynécologique courante en dehors de l'état de grossesse. Elles sont resporlsables pour la plupart des ménorragies, des métrorragies, des rl1énométrorragies, des pelvialgies, des avortements à répétition et des infertilités chez la femme en activité génitale. Chez la femme ménopausée, le saignement vaginal anormal reste leur principale traduction clinique.

French

Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure.

Billong SC, Dee J, Fokam J, Nguefack-Tsague G, Ekali GL, Fodjo R, Temgoua ES, Billong E-J, Sosso SM, Mosoko JJ et al..  2017.  Feasibility Study of HIV Sentinel Surveillance using PMTCT data in Cameroon: from Scientific Success to Programmatic Failure.. BMC Infect Dis. 17(1):3.
French

Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.

Fokam J, Billong SClotaire, Jogue F, Ndiang SMoyo Tetan, Motaze ACarole Nga, Paul KNdombo, Nlend AEsther Njo.  2017.  Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.. PLoS One. 12(11):e0187566.
French

Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis.

Anoubissi Jde Dieu, Gabriel ELoni, Nde CKengne, Fokam J, Tseuko DGodelive, Messeh A, Moussa Y, Nkenfou CNguefeu, Bonono L, Billong S-C et al..  2019.  Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis.. PLoS One. 14(4):e0208963.
French

Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.

Galy A, Ciaffi L, Le Moing V, Eymard-Duvernay S, Abessolo H, Toby R, Ayangma L, Le Gac S, Mpoudi-Etame M, Koulla-Shiro S et al..  2016.  Incidence of infectious morbidity events after second-line antiretroviral therapy initiation in HIV-infected adults in Yaoundé, Cameroon.. Antivir Ther. 21(6):547-552.
French

Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.

Serris A, Zoungrana J, Diallo M, Toby R, Ngolle MMpoudi, Le Gac S, Coutherut J, Cournil A, De Beaudrap P, Koulla-Shiro S et al..  2016.  Getting pregnant in HIV clinical trials: women's choice and safety needs. The experience from the ANRS12169-2LADY and ANRS12286-MOBIDIP trials.. HIV Clin Trials. 17(6):233-241.
French

Pages